CHOIW.Y., KIMG.Y., LEEW.H., CHOIY.H.2008. Sanguinarine, a benzophenanthridine alkaloid, induces apoptosis in MDA-MB-231 human breast carcinoma cells through a reactive oxygen species-mediated mitochondrial pathway. Chemotherapy, 54:279–287.
2.
CHOIY.H., CHOIW.Y., HONGS.H.et al.2009. Anti-invasive activity of sanguinarine through modulation of tight junctions and matrix metalloproteinase activities in MDA-MB-231 human breast carcinoma cells. Chem. Biol. Interact., 179:185–191.
3.
JANGB.C., PARKJ.G., SONGD.K.et al.2009. Sanguinarine induces apoptosis in A549 human lung cancer cells primarily via cellular glutathione depletion. Toxicol. In Vitro, 23:281–287.
4.
JIX., SUNH., ZHOUH., XIANGJ., TANGY., ZHAOC.2012. The interaction of telomeric DNA and C-myc22 G-quadruplex with 11 natural alkaloids. Nucleic Acid Ther., 22:127–136.
5.
LEEJ.S., JUNGW.K., JEONGM.H., YOONT.R., KIMH.K.2012. Sanguinarine induces apoptosis of HT-29 human colon cancer cells via the regulation of Bax/Bcl-2 ratio and caspase-9-dependent pathway. Int. J. Toxicol., 31:70–77.
6.
PICAF., BALESTRIERIE., SERAFINOA.et al.2012. Antitumor effects of the benzophenanthridine alkaloid sanguinarine in a rat syngeneic model of colorectal cancer. Anticancer Drugs, 23:32–42.
7.
XUJ.Y., MENGQ.H., CHONGY.et al.2012. Sanguinarine inhibits growth of human cervical cancer cells through the induction of apoptosis. Oncol. Rep., 28:2264–2270.
